27653-22-1Relevant articles and documents
Iron-Catalyzed Reductive Metalation-Allylation and Metalative Cyclization of 2,3-Disubstituted Oxetanes and Their Stereoselectivity
Sugiyama, Yu-Ki,Heigozono, Shiori,Tamura, Kazuhiro,Okamoto, Sentaro
, p. 2823 - 2828 (2016)
A novel process for the reductive magnesiation of 2-substituted oxetanes and the metalative cyclization of ω-alkynyl oxetanes is developed using n-propylmagnesium chloride in the presence of an iron catalyst. The generated intermediate organomagnesium compounds react with electrophiles. The reactions of 2,3-disubstituted oxetanes and their subsequent allylation with allyl halides in the presence or absence of copper(I) cyanide as the catalyst is studied with a unique switching of stereoselectivity being observed in the absence or presence of copper(I) cyanide. In addition, it is found that the metalative cyclization of 3-substituted 2-alkynyl oxetanes proceeds in an anti-selective manner starting from both syn- and anti-substrates. In all cases, the stereochemistry at the 2-position of the oxetanes is lost during the reactions suggesting the involvement of a radical process.
ANTICANCER 1,3-DIOXANE-4,6-DIONE DERIVATIVES AND METHOD OF COMBINATORIAL SYNTHESIS THEREOF
-
Paragraph 0244-0246, (2020/12/14)
Compounds, methods of synthesis, and methods of cancer treatment by arylidene-1,3-dioxane-4,6-diones. A Meldrum's acid-based chemistry and hybrid solid-liquid method. The method includes protection of ketone and aldehyde components and simultaneous immobilization on the solid phase, introduction of substituents, grafts and derivatives compatible with the protection, detachment and restoration of active carbonyl reactivity, reaction of ketone library with malonate, reacting of the products with the aldehyde library in liquid phase and separation of the products by preparative HPLC.
Biocatalytic reduction of α,β-unsaturated carboxylic acids to allylic alcohols
Aleku, Godwin A.,Leys, David,Roberts, George W.
, p. 3927 - 3939 (2020/07/09)
We have developed robust in vivo and in vitro biocatalytic systems that enable reduction of α,β-unsaturated carboxylic acids to allylic alcohols and their saturated analogues. These compounds are prevalent scaffolds in many industrial chemicals and pharmaceuticals. A substrate profiling study of a carboxylic acid reductase (CAR) investigating unexplored substrate space, such as benzo-fused (hetero)aromatic carboxylic acids and α,β-unsaturated carboxylic acids, revealed broad substrate tolerance and provided information on the reactivity patterns of these substrates. E. coli cells expressing a heterologous CAR were employed as a multi-step hydrogenation catalyst to convert a variety of α,β-unsaturated carboxylic acids to the corresponding saturated primary alcohols, affording up to >99percent conversion. This was supported by the broad substrate scope of E. coli endogenous alcohol dehydrogenase (ADH), as well as the unexpected CC bond reducing activity of E. coli cells. In addition, a broad range of benzofused (hetero)aromatic carboxylic acids were converted to the corresponding primary alcohols by the recombinant E. coli cells. An alternative one-pot in vitro two-enzyme system, consisting of CAR and glucose dehydrogenase (GDH), demonstrates promiscuous carbonyl reductase activity of GDH towards a wide range of unsaturated aldehydes. Hence, coupling CAR with a GDH-driven NADP(H) recycling system provides access to a variety of (hetero)aromatic primary alcohols and allylic alcohols from the parent carboxylates, in up to >99percent conversion. To demonstrate the applicability of these systems in preparative synthesis, we performed 100 mg scale biotransformations for the preparation of indole-3-aldehyde and 3-(naphthalen-1-yl)propan-1-ol using the whole-cell system, and cinnamyl alcohol using the in vitro system, affording up to 85percent isolated yield.
